fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Abbott India Ltd

Abbott India Ltd

Updated on November 12, 2019

Stock/Share Code - ABBOTINDIA

Abbott India is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.(Source : 201903 Annual Report Page No: 58)

Below is the details of ABBOTINDIA Abbott India Ltd

Market Cap₹19,441 Cr.
Current Price ₹12,365 as on 15 Nov 19
52 Week High / Low Price₹9,427.1 / ₹6,900
Face Value₹10
Stock P/E40.10
Book Value₹945.22
Dividend Yield0.71 %
ROCE37.36 %
ROE24.00 %
Sales Growth (3yrs)12.06 %
SectorPharmaceuticals
IndustryPharmaceuticals - Multinational
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 30.18%
Cons: Stock is trading at 9.68 times its book value The company has delivered a poor growth of 10.08% over past five years.

Abbott India Ltd Price Chart

Abbott India Ltd Price Chart

Abbott India Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Glaxosmi. Pharma ₹14.25 48.35 ₹20,586.22 Cr. 1.65 ₹113.54 Cr. 27.17 7.11 787.97 31.11
2. Abbott India 40.10 ₹19,440.78 Cr. 0.71 ₹116.94 Cr. 41.92 18.22 998.89 37.36
3. Sanofi India ₹6,487.65 36.36 ₹14,138.35 Cr. 1.37 ₹97.4 Cr. -2.21 9.41 747.90 28.84
4. Pfizer ₹3,980.75 29.74 ₹13,382.81 Cr. 0.77 ₹112.81 Cr. 22.83 6.26 544.40 23.22
5. Proc. Gam. Heal. ₹129.85 8.01 ₹6,830.07 Cr. 10.69 ₹44.08 Cr. -8.76 6.06 233.63 78.16
6. Astrazeneca Phar ₹2,622.85 67.59 ₹4,701.63 Cr. 0.00 ₹21.52 Cr. 236.78 26.71 204.56 26.51
7. Novartis India ₹69.35 62.57 ₹1,401.57 Cr. 1.76 ₹0.79 Cr. -92.10 -20.85 109.31 7.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Abbott India Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Sales721747706698931881788845980948906999
YOY Sales Growth %11.11%11.5%3.19%-4.33%29.1%18.08%11.72%21.1%5.24%7.51%14.96%18.22%
Expenses615623643644730718682734786801753825
Material Cost %59.59%59.02%59.85%62.78%56.02%58.24%54.78%56.33%57.14%57.89%55.63%56.06%
Employee Cost %12.04%11.77%12.01%13.85%10.56%10.34%13.65%13.58%10.73%11.22%12.06%12.03%
Operating Profit1061236353201163107111194146153174
OPM %15%16%9%8%22%19%14%13%20%15%17%17%
Other Income141415241519592225382930
Interest002111211012
Depreciation4444444444515
Profit before tax1161337273212178159129214180177187
Tax %35%35%42%34%35%35%37%36%36%35%36%37%
Net Profit7586424813811510082138117113117
EPS in Rs35.3040.2619.7922.7164.7254.3047.1038.7864.7955.0853.2855.03
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales5946667619901,4901,6532,2762,2892,6142,9033,2983,6793,833
Sales Growth %16.48%12.06%14.25%30.09%50.54%10.9%37.71%0.59%14.2%11.02%13.64%11.52%%
Expenses5135906639201,3151,4702,0091,9772,2502,5052,7743,0743,165
Material Cost %68.73%68.26%66.26%65.39%57.79%58.79%57.01%57.31%57.07%58.98%57.75%56.78%%
Manufacturing Cost %1.41%1.67%1.63%1.58%0.95%1.12%1.28%0.88%0.82%0.82%1.46%1.43%%
Employee Cost %5.54%6.87%7.84%10.92%11.23%12.48%13.17%13.34%13.05%11.9%11.94%11.84%%
Other Cost %15.33%16.3%15.88%19.83%18.25%16.53%16.8%14.84%15.12%14.61%12.95%13.52%%
Operating Profit82769770176183267312365398525605668
OPM %14%11%13%7%12%11%12%14%14%14%16%16%17%
Other Income26262936205149485057117113121
Interest0000000032424
Depreciation67911151922151416161728
Profit before tax1029411794180215295344398436621699757
Tax %33%33%34%35%33%33%33%34%36%37%35%36%
Net Profit68637861120145198229255277401450485
EPS in Rs43.9443.5853.7738.5253.9065.3471.59101.44120.12130.19188.81211.93228.18
Dividend Payout %37%30%30%38%30%25%25%29%29%31%29%31%

Compounded Sales Growth

  • 10 Years:: 18.64%
  • 5 Years:: 10.08%
  • 3 Years:: 12.06%
  • TTM:: 11.23%

Compounded Profit Growth

  • 10 Years:: 22.05%
  • 5 Years:: 18.43%
  • 3 Years:: 20.25%
  • TTM:: 11.36%

Return on Equity

  • 10 Years:: 24.68%
  • 5 Years:: 24.29%
  • 3 Years:: 23.97%
  • Last Year:: 24.00%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital141414142121212121212121
Equity Capital14.4713.6813.6813.6821.2521.2521.2521.2521.2521.2521.2521.25
Reserves2172082582925236267679161,1741,3661,6721,987
Borrowings110000000000
Other Liabilities100131119152258272363445431688735946
Trade Payables30.8471.0843.1157.75120.9103.47136.26193.6232.94474.73480.66663.52
Total Liabilities3323533914578029191,1511,3821,6272,0752,4282,955
Fixed Assets3548495080109989610811081105
Gross Block80.0598.72107.1118.21191.81203.65209.23215.65122.83139.69124.25164.52
Accumulated Depreciation44.8550.7958.3168.5112.1594.98110.98119.6114.3730.142.8759.56
CWIP130101143621
Investments15000000000000
Other Assets1463023424077228091,0511,2821,5151,9592,3442,849
Inventories86.3992.12102.38128.59254.9263.63359.05384.13370.1500.63585.33606.79
Trade receivables30.3432.3744.465.28132.61141.03109.18129.15145.02176.22263.44276.11
Cash Equivalents17.22163.54175.61188.51258.95323.34462.84643.89839.421090.921031.351684.28
Loans n Advances11.7113.9319.3924.3950.3557.3378.1684.14115.49146.96411.62220.78
Other Assets etc00002524.0641.941.0445.244.5252.5761.17
Total Assets3323533914578029191,1511,3821,6272,0752,4282,955

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity3187374624101155215249307153499
Profit from operations96.4991.95121.73100.72181.56205.76293.48307.17374.03399.48544.56621.39
Working Capital Changes-32.631.2-46.35-5.62-97.28-39.78-28.4523.4821.8566.52-186.96134.41
Taxes paid-33.15-35.94-38.22-49.04-60.21-64.63-109.72-115.87-147.2-158.78-204.9-256.67
Cash from Investing Activity57140-1-1656-59-144-187-77-155-215-257
Fixed Assets Purchased-10.94-21.49-7.92-12.13-15.5-17.26-18.05-18.06-22.72-20.66-24.26-12.49
Fixed Assets Sold2.320.130.10.120.240.2413.952.540.060.1451.5916.95
Investments purchased-98.04-2400-0.240000000
Investments sold163.2179.890036.90000000
Cash from Financing Activity-83-81-23-27-42-42-42-58-80-90-102-143
Repayment of Borrowings-0.38-0.27-0.77000000000
Interest Paid-0.02-0.02-0.2-0.03-0.03-0.02-0.08-0.12-1.01-0.25-0.13-1.9
Dividends Paid-29.63-29.63-22.4-27.2-41.99-41.99-42.27-48.87-65.87-74.37-85-116.87
Net Cash Flow4146133381-31-309162-16599

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %41%40%48%33%42%34%39%40%38%34%41%37%
Debtor Days191821243231182120222927
Inventory Turnover8.427.467.828.577.776.377.316.166.936.676.076.17

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Abbott India Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.